Materia Malta Begins First Sales of Medical Cannabis in Europe
1.3 min readPublished On: December 17th, 2021By News Team
LONDON, England – Materia today announced they have commenced sales of the first medical cannabis flower produced at its EU GMP certified manufacturing site.
The inaugural product, named Carbasi Verde, was released with a potency of 21.7% THC following successful completion of Materia Malta’s first production cycle, which includes hand trimming to ensure the best quality for patients.
Members of the Materia Malta team prepare Carbasi Verde for sale.
Carbasi Verde is now available at pharmacies across Malta, with subsequent shipments planned for Germany and the UK. The product has already been registered on the narcotics license of Materia Deutschland GmbH ahead of its import into Germany.
“This journey began in earnest over two years ago, so we’re elated to be offering patients Materia manufactured and branded medical cannabis,” said Nick Pateras, Managing Director, Europe, of Materia. “Our Maltese site is truly state-of-the-art, and with our team’s deep pharmaceuticals expertise we’re confident that Materia Malta will become one of the most important production facilities in Europe’s cannabis supply chain.”
Malta Enterprise, the government’s economic development agency, offered its own congratulations to the Company. “Materia has been at the forefront of Malta’s cannabis industry since we moved quickly to become a European leader in this field,” said Kurt Farruga, CEO of Malta Enterprise. “We’re extremely proud to see locally produced medicinal products available to Maltese patients and are excited to continue supporting Materia’s talented team as the Company expands its presence across the continent.”
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
BOCA RATON, Fla. - ACS Laboratory, hemp and cannabis testing facility in the eastern U.S., has developed the THCOa Safety Bundle Test, a testing panel to test for THC-O Acetate (THCOa), acetic anhydride and other ...
ROXBORO, N.C. - Open Book Extracts (OBX), a cGMP-certified manufacturer and distributor of the industry's quality cannabinoid ingredients and finished products, announced the addition of Tony Reeves and Tony Scanlan to its European sales and ...
WAKEFIELD, Mass. - Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), an international provider of consumer products in cannabis, announced the completion of its previously announced acquisition of Bloom Dispensaries, a single state cannabis operator ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more